Unihealth Hospitals Ltd Stock Price Today (NSE: UNIHEALTH)
Fundamental Score
Unihealth Hospitals Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Unihealth Hospitals Ltd share price today is ₹342.30, up +0.00% on NSE/BSE as of 2 January 2026. Unihealth Hospitals Ltd (UNIHEALTH) is a Small-cap company in the Hospital sector with a market capitalisation of ₹530.56 (Cr). The 52-week high for UNIHEALTH share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 22.00x, UNIHEALTH is currently trading below its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 16.03% and a debt-to-equity ratio of 0.14.
Unihealth Hospitals Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Unihealth Hospitals Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Unihealth Hospitals Share Price: A Financial Analysis for Growth
The healthcare sector presents a unique dynamic: demand is relatively inelastic, yet operational efficiency and strategic network expansion are crucial for achieving industry dominance. This analysis examines the financial health of Unihealth Hospitals, focusing on factors influencing its valuation. We are looking at the Unihealth Hospitals share price, currently trading at ₹342.3, within the context of its financial metrics and peer performance. This is part of an 80-parameter fundamental audit verified by Sweta Mishra.
A key indicator of valuation is the Price-to-Earnings (PE) ratio. Unihealth Hospitals Ltd's PE of 22.0 suggests the market expects continued earnings growth. However, context is critical. Comparing this to peers like
Nephro Care India Limited requires considering qualitative factors, such as management quality and strategic vision. While Nephro Care India Limited might boast similar financial metrics, a deeper dive into its leadership’s experience and execution track record is necessary to assess long-term growth potential relative to Unihealth Hospitals.Return on Capital Employed (ROCE) is a vital metric for understanding a company's ability to generate profits from its invested capital. Unihealth Hospitals Ltd demonstrates a ROCE of 17.15%. This is a strong showing. ROCE shows how much money a company is making for every dollar of capital employed, This metric indicates efficient capital allocation and contributes to building a sustainable economic moat. A consistently high ROCE compared to competitors suggests a stronger competitive advantage, allowing Unihealth Hospitals to potentially reinvest profits for expansion or weather economic downturns more effectively.
Ultimately, evaluating the fair value of Unihealth Hospitals requires a comprehensive review of various factors beyond these initial observations. Considerations should include debt levels, revenue growth trends, and the competitive landscape, including players like Strategic Minerals Plc and Abateas Industries Ltd.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Unihealth Hospitals Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of UNIHEALTH across key market metrics for learning purposes.
Positive Indicators
12 factors identified
Strong Return on Equity (16.03%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (17.15%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (32.10%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 22.00 vs Industry: 52.84)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (195.12%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (54.08%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (20.12% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (75.91% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.14)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (20.53x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (69.14%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Limited Institutional Interest (FII+DII: 0.75%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Unihealth Hospitals Ltd Financial Statements
Comprehensive financial data for Unihealth Hospitals Ltd including income statement, balance sheet and cash flow
About UNIHEALTH (Unihealth Hospitals Ltd)
Unihealth Hospitals Ltd (UNIHEALTH) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a current market capitalisation of ₹530.56 (Cr). Unihealth Hospitals Ltd has delivered a Return on Equity (ROE) of 16.03% and a ROCE of 17.15%. The debt-to-equity ratio stands at 0.14, reflecting the company's capital structure. Investors tracking UNIHEALTH share price can monitor key metrics including P/E ratio, promoter holding of 69.14%, and quarterly earnings growth.
Company Details
UNIHEALTH Share Price: Frequently Asked Questions
What is the current share price of Unihealth Hospitals Ltd (UNIHEALTH)?
As of 02 Jan 2026, 03:46 pm IST, Unihealth Hospitals Ltd share price is ₹342.30. The UNIHEALTH stock has a market capitalisation of ₹530.56 (Cr) on NSE/BSE.
Is UNIHEALTH share price Overvalued or Undervalued?
UNIHEALTH share price is currently trading at a P/E ratio of 22.00x, compared to the industry average of 52.84x. Based on this relative valuation, the Unihealth Hospitals Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of UNIHEALTH share price?
The 52-week high of UNIHEALTH share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Unihealth Hospitals Ltd share price?
Key factors influencing UNIHEALTH share price include quarterly earnings growth (Sales Growth: 54.08%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Unihealth Hospitals Ltd a good stock for long-term investment?
Unihealth Hospitals Ltd shows a 5-year Profit Growth of 75.91% and an ROE of 16.03%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.14 before investing in UNIHEALTH shares.
How does Unihealth Hospitals Ltd compare with its industry peers?
Unihealth Hospitals Ltd competes with major peers in the Hospital. Investors should compare UNIHEALTH share price P/E of 22.00x and ROE of 16.03% against the industry averages to determine competitive standing.
What is the P/E ratio of UNIHEALTH and what does it mean?
UNIHEALTH share price has a P/E ratio of 22.00x compared to the industry average of 52.84x. Investors pay ₹22 for every ₹1 of annual earnings.
How is UNIHEALTH performing according to Bull Run's analysis?
UNIHEALTH has a Bull Run fundamental score of 62.59999999999999/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does UNIHEALTH belong to?
UNIHEALTH operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Unihealth Hospitals Ltd share price.
What is Return on Equity (ROE) and why is it important for UNIHEALTH?
UNIHEALTH has an ROE of 16.03%, which indicates excellent management efficiency. ROE measures how efficiently Unihealth Hospitals Ltd generates profits from shareholders capital.
How is UNIHEALTH debt-to-equity ratio and what does it indicate?
UNIHEALTH has a debt-to-equity ratio of 0.14, which indicates conservative financing with low financial risk.
What is UNIHEALTH dividend yield and is it a good dividend stock?
UNIHEALTH offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Unihealth Hospitals Ltd shares.
How has UNIHEALTH share price grown over the past 5 years?
UNIHEALTH has achieved 5-year growth rates of: Sales Growth 20.12%, Profit Growth 75.91%, and EPS Growth N/A%.
What is the promoter holding in UNIHEALTH and why does it matter?
Promoters hold 69.14% of UNIHEALTH shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Unihealth Hospitals Ltd.
What is UNIHEALTH market capitalisation category?
UNIHEALTH has a market capitalisation of ₹531 crores, placing it in the Small-cap category.
How volatile is UNIHEALTH stock?
UNIHEALTH has a beta of N/A. A beta > 1 suggests the Unihealth Hospitals Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is UNIHEALTH operating profit margin trend?
UNIHEALTH has a 5-year average Operating Profit Margin (OPM) of 32.10%, indicating the company's operational efficiency.
How is UNIHEALTH quarterly performance?
Recent quarterly performance shows Unihealth Hospitals Ltd YoY Sales Growth of 54.08% and YoY Profit Growth of 195.12%.
What is the institutional holding pattern in UNIHEALTH?
UNIHEALTH has FII holding of 0.00% and DII holding of 0.75%. Significant institutional holding often suggests professional confidence in the Unihealth Hospitals Ltd stock.